معرفی
Don Ingber is a leading bioengineer and vascular biologist at Harvard University, serving as Founding Director of the Wyss Institute for Biologically Inspired Engineering and Professor at the Harvard John A. Paulson School of Engineering and Applied Sciences. He holds the Judah Folkman Professorship in Vascular Biology at Harvard Medical School and is affiliated with Boston Children's Hospital's Vascular Biology Program. His research integrates engineering, physics, and molecular biology to understand how mechanical forces and cellular structure influence disease and tissue development. Key contributions include pioneering work in angiogenesis, organ-on-a-chip technology, and mechanobiology.
Ingber's education includes an MD and PhD from Yale University, followed by postdoctoral training at Children's Hospital Boston. His lab focuses on disease modeling (e.g., cancer, inflammatory bowel disease), drug discovery, and regenerative medicine using organ chip platforms. He has over 20 patents and led the development of TNP-470, one of the first angiogenesis inhibitors.
Research interests span mechanotransduction, systems biology, and bioinspired engineering, with applications in precision medicine and drug development. Recent work includes modeling vaginal microbiome interactions, radiation injury in gut chips, and therapeutic targets for COPD exacerbations.
Scientific achievements include election to the National Academy of Engineering. His labs and teams have advanced microphysiological systems for predictive toxicology and personalized medicine, emphasizing interdisciplinary approaches to biomedical challenges.
